| Regulation and functions of inflammasome-mediated cytokines in Helicobacter pylori infection M Chonwerawong, RL Ferrero Microbes and infection 19 (9-10), 449-458, 2017 | 24 | 2017 |
| Mouse models of Helicobacter infection and gastric pathologies K D'Costa, M Chonwerawong, RL Ferrero JoVE (Journal of Visualized Experiments), e56985, 2018 | 14 | 2018 |
| Innate immune molecule NLRC5 protects mice from Helicobacter-induced formation of gastric lymphoid tissue M Chonwerawong, J Ferrand, HM Chaudhry, C Higgins, MM Walker, ... Gastroenterology 159 (1), 169-182. e8, 2020 | 13 | 2020 |
| The microbiome and host mucosal interactions in urinary tract diseases B Jones-Freeman, M Chonwerawong, VR Marcelino, AV Deshpande, ... Mucosal Immunology 14 (4), 779-792, 2021 | 11 | 2021 |
| Key Technologies for Progressing Discovery of Microbiome-Based Medicines RB Young, VR Marcelino, M Chonwerawong, EL Gulliver, SC Forster Frontiers in Microbiology 12, 1604, 2021 | 5 | 2021 |
| Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice M Chonwerawong, P Avé, M Huerre, RL Ferrero Gut pathogens 8 (1), 1-9, 2016 | 5 | 2016 |
| Analysis of Innate Immune Responses to Helicobacter pylori M Chonwerawong, RL Ferrero Helicobacter Pylori, 191-214, 2021 | 1 | 2021 |
| Toll-like receptor 9 promotes initiation of gastric tumorigenesis by augmenting inflammation and cellular proliferation K Tang, L McLeod, T Livis, AC West, R Dawson, L Yu, JJ Balic, ... Cellular and Molecular Gastroenterology and Hepatology, 2022 | | 2022 |
| the future of microbiome‐based therapeutics EL Gulliver, RB Young, M Chonwerawong, GL D'Adamo, T Thomason, ... Alimentary Pharmacology & Therapeutics, 2022 | | 2022 |
Samuel C. ForsterHudson Institute of Medical Research and Wellcome Trust Sanger InstituteVerified email at sanger.ac.uk
